Investor information
Cash distributions per share
| Year | Amount in CHF | Ex-date | Payment date |
|---|---|---|---|
| 2026 | 9.00 | 17.6.2026 | 19.6.2026 |
| 2025 | 4.90 2.60 | 02.07.2025 02.07.2025 | 04.07.2025 Dividend 04.07.2025 Par Value Repayment |
| 2024 | 7.50 | 07.08.2024 | 09.08.2024 |
| 2023 | 7.50 | 03.08.2023 | 07.08.2023 |
| 2022 | 9.70 | 30.08.2022 | 01.09.2022 |
| 2021 | 3.00 9.50 | 07.09.2021 07.09.2021 | 09.09.2021 Anniversary Payment 09.09.2021 Ordinary Distribution |
| 2020 | 7.70 | 08.09.2020 | 10.09.2020 |
| 2019 | 7.50 | 10.09.2019 | 12.09.2019 |
| 2018 | 5.50 1.50 | 27.06.2018 19.09.2018 | 29.06.2018 21.09.2018 |
| 2017 | 5.80 | 28.06.2017 | 30.06.2017 |
| 2016 | 5.50 | 28.06.2016 | 30.06.2016 |
| 2015 | 5.50 | 01.07.2015 | 06.07.2015 |
| 2014 | 3.00 | 24.06.2014 | 27.06.2014 |
| 2013 | 1.50 | 04.09.2013 | 09.09.2013 |
Significant shareholders
Based on the notifications received by the Company, the following shareholders reported equity holdings in HBM Healthcare Investments Ltd of three percent or more:
| Shareholding | Shareholder |
|---|---|
| 15 - 20% | Nogra Pharma Invest S.à.r.l. / GG 1978 SICAF SIF S.A. "GG Strategic" / MGG STRATEGIC SICAF SIF S.A. "MGG Strategic", Luxembourg |
| 10 - 15% | Saba Capital Management, L.P., USA |
| 3 - 5% | HBM Healthcare Investments (Cayman) Ltd. |
See here for details about significant shareholders in HBM Healthcare Investments Ltd. (SIX Swiss Exchange).
Fees
Management fees (paid quarterly):
0.75% of company assets plus
0.75% of the company's market capitalisation
Performance fee (paid annually):
15% on increase in value above the high water mark. High water mark (per share for all outstanding shares) for financial year 2026/2027: NAV of CHF 274.07.
Presentations
HBM Healthcare Investments Company Presentation
HBM Healthcare Investments Factsheet
HBM Healthcare Investments Key Investor Information (KIID)
HBM Healthcare Investments Key Information Document (PRIIPS-KID)
Analyst reports
CIC Market Solutions Report July 2026
Baader Europe Report July 2026
CIC Market Solutions Report May 2026
Baader Helvea Report March 2026
Baader Helvea Report January 2026
CIC Market Solutions Report January 2026
Baader Helvea Report July 2025
Management transactions
See here for details about Management transactions in HBM Healthcare Investments' shares (SIX Swiss Exchange).
Articles of association
Articles of Association of HBM Healthcare Investments Ltd. (German)
Share buy-back programme
Share buy-back programme 2025
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 1'630 shares.
HBM Healthcare Investments launches a new share buy-back programme
Rückkauf eigener Aktien zum Zweck der Kapitalherabsetzung (German)
Rachat d’actions propres dans le but d’une réduction de capital (French)
Share buy-back programme 2022 (completed)
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 1'047 shares.
HBM Healthcare Investments launches a new share buy-back programme
Rückkauf eigener Aktien zum Zweck der Kapitalherabsetzung (German)
Rachat d’actions propres dans le but d’une réduction de capital (French)